|
| | SB1882 Enrolled | | LRB103 27260 RLC 53631 b |
|
|
1 | | AN ACT concerning animals.
|
2 | | Be it enacted by the People of the State of Illinois,
|
3 | | represented in the General Assembly:
|
4 | | Section 1. Short title. This Act may be cited as the |
5 | | Protection of Dogs and Cats from Unnecessary Testing Act. |
6 | | Section 5. Definitions. In this Act: |
7 | | "Alternative test method" means a test method that does |
8 | | not use animals, or in some cases reduces or refines the use of |
9 | | animals, for which the reliability and relevance for a |
10 | | specific purpose has been established by validation bodies, |
11 | | including, but not limited to, the Inter-Agency Coordinating |
12 | | Committee for the Validation of Alternative Methods and the |
13 | | Organisation for Economic Co-operation and Development. |
14 | | Alternative test methods include, but are not limited to, |
15 | | high-throughput screening methods, testing of categories of |
16 | | chemical substances, tiered testing methods, in vitro studies, |
17 | | and systems biology.
|
18 | | "Cat" means a small domesticated carnivorous mammal that |
19 | | is a member of the family Felidae, order Carnivora.
|
20 | | "Canine or feline toxicological experiment" means any test |
21 | | or study of any duration that seeks to determine the effect, if |
22 | | any, of the application or exposure, whether internal or |
23 | | external, of any amount of a chemical substance on a dog or |
|
| | SB1882 Enrolled | - 2 - | LRB103 27260 RLC 53631 b |
|
|
1 | | cat. "Application or exposure" includes, but is not limited |
2 | | to, oral ingestion, skin or eye contact, or inhalation. |
3 | | "Application or exposure" does not include testing of |
4 | | veterinary products for canine or feline health.
|
5 | | "Chemical substance" means any organic or inorganic |
6 | | substance, including, but not limited to, a drug, as defined |
7 | | in Section 321(g) of Title 21 of the United States Code, a |
8 | | pesticide, as defined in Section 136(u) of Title 7 of the |
9 | | United States Code, a chemical substance, as defined in |
10 | | Section 2602(2) of Title 15 of the United States Code, or a |
11 | | food additive, as defined in Section 321(s) of Title 21 of the |
12 | | United States Code.
|
13 | | "Testing facility" means any partnership, corporation, |
14 | | association, school, institution, organization, or other legal |
15 | | relationship, whether privately or government owned, leased, |
16 | | or operated, that tests chemicals, ingredients, product |
17 | | formulations, or products in this State.
|
18 | | "Dog" means any member of the species Canis familiaris.
|
19 | | "Medical research" means research related to the causes, |
20 | | progression, diagnosis, treatment, control, or prevention of |
21 | | physical or mental diseases and impairments or chronic |
22 | | conditions of humans or animals or related to the development |
23 | | of biomedical products or devices, as defined under Section |
24 | | 321(h) of Title 21 of the United States Code. Medical research |
25 | | does not include research related to the development of drugs |
26 | | as defined in Section 321(g)(1) of Title 21 of the United |
|
| | SB1882 Enrolled | - 3 - | LRB103 27260 RLC 53631 b |
|
|
1 | | States Code.
|
2 | | Section 10. Prohibition on the use of dogs or cats in |
3 | | toxicological experiments; exemptions; enforcement.
|
4 | | (a) Notwithstanding any law to the contrary, and in |
5 | | addition to the prohibitions set forth in law, a testing |
6 | | facility shall not conduct a canine or feline toxicological |
7 | | experiment in this State unless the experiment is conducted |
8 | | for any of the following purposes:
|
9 | | (1) Medical research.
|
10 | | (2) To comply with federal requirements pertaining to |
11 | | the approval or maintenance of a medical device, as |
12 | | defined under Section 321(h) of Title 21 of the United |
13 | | States Code.
|
14 | | (3) To achieve discovery, approval, or maintenance of |
15 | | a drug, pursuant to a testing requirement imposed by the |
16 | | United States Food and Drug Administration under Section |
17 | | 505 or 512 of the Federal Food, Drug, and Cosmetic Act or |
18 | | Section 351 of the Public Health Service Act or any |
19 | | binding agency regulation promulgated upon notice and |
20 | | comment thereunder, if the United States Food and Drug |
21 | | Administration has not otherwise expressly authorized drug |
22 | | manufacturers to use alternative test methods.
|
23 | | (4) To achieve discovery, approval, or maintenance of |
24 | | a biologic, pursuant to a testing requirement imposed by |
25 | | the United States Department of Agriculture under the |
|
| | SB1882 Enrolled | - 4 - | LRB103 27260 RLC 53631 b |
|
|
1 | | Virus-Serum-Toxin Act or any binding agency regulation |
2 | | promulgated upon notice and comment thereunder, if the |
3 | | United States Department of Agriculture has not concluded |
4 | | that waivers shall be granted for the experimentation or |
5 | | studies or expressly indicated acceptance of alternative |
6 | | test methods.
|
7 | | (5) To achieve discovery, approval, registration, or |
8 | | maintenance of a pesticide, pursuant to a testing |
9 | | requirement imposed by the United States Environmental |
10 | | Protection Agency pursuant to the Federal Insecticide, |
11 | | Fungicide, and Rodenticide Act, or any binding agency |
12 | | regulation promulgated upon notice and comment thereunder, |
13 | | if the Environmental Protection Agency has not concluded |
14 | | that waivers shall be granted for such experimentation or |
15 | | studies or expressly indicated acceptance of alternative |
16 | | test methods.
|
17 | | (6) To comply with a requirement to conduct the |
18 | | experiment under the Toxic Substances Control Act, if the |
19 | | United States Environmental Protection Agency has not, |
20 | | pursuant to Section 2603(h) of Title 15 of the United |
21 | | States Code, concluded that waivers shall be granted for |
22 | | such experimentation or studies or expressly indicated |
23 | | acceptance of testing methods alternative to laboratory |
24 | | animal testing, including, but not limited to, in vitro, |
25 | | in silico, and in chemico approaches for identifying skin |
26 | | sensitization hazards.
|
|
| | SB1882 Enrolled | - 5 - | LRB103 27260 RLC 53631 b |
|
|
1 | | (b)(1) The Attorney General or a State's Attorney in the |
2 | | county in which a violation of this Act occurred may bring an |
3 | | action in the name of the People of the State to enforce the |
4 | | provisions of this Act.
|
5 | | (2) Whenever the Attorney General, or a State's Attorney |
6 | | in the county in which a violation of this Act occurred, has |
7 | | reason to believe that a testing facility has in engaged in or |
8 | | is engaging in any practice in violation of this Act, and that |
9 | | proceedings would be in the public interest, he or she may |
10 | | bring an action in the name of the People of the State against |
11 | | such testing facility to restrain by preliminary or permanent |
12 | | injunction the use of that practice.
|
13 | | (3) If the court determines that the Attorney General or |
14 | | State's Attorney is the prevailing party in an action filed |
15 | | pursuant to paragraph (1), the official may recover a civil |
16 | | penalty not to exceed $5,000 for each day that each dog or each |
17 | | cat is used in a canine or feline toxicological experiment in |
18 | | violation of this Section. In addition to the civil penalty, |
19 | | the official may also recover court costs and attorney's fees.
|
20 | | (c) The prohibition in subsection (a) does not apply to |
21 | | testing or experimentation conducted for the purpose of |
22 | | developing, manufacturing, or marketing any product intended |
23 | | for beneficial use in dogs or cats.
|
24 | | Section 97. Severability. The provisions of this Act are |
25 | | severable under Section 1.31 of the Statute on Statutes. |